South Africa Anticoagulants Market Size & Outlook

The anticoagulants market in South Africa is expected to reach a projected revenue of US$ 114.2 million by 2033. A compound annual growth rate of 4.1% is expected of South Africa anticoagulants market from 2026 to 2033.
Revenue, 2025 (US$M)
$83.7
Forecast, 2033 (US$M)
$114.2
CAGR, 2026 - 2033
4.1%
Report Coverage
South Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa anticoagulants market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa anticoagulants market highlights

  • The South Africa anticoagulants market generated a revenue of USD 83.7 million in 2025 and is expected to reach USD 114.2 million by 2033.
  • The South Africa market is expected to grow at a CAGR of 4.1% from 2026 to 2033.
  • In terms of segment, novel oral anticoagulants (noacs) was the largest revenue generating drug category in 2025.
  • Direct Thrombin Inhibitors is the most lucrative drug category segment registering the fastest growth during the forecast period.


Anticoagulants market data book summary

Market revenue in 2025USD 83.7 million
Market revenue in 2033USD 114.2 million
Growth rate4.1% (CAGR from 2026 to 2033)
Largest segmentNovel oral anticoagulants (noacs)
Fastest growing segmentDirect Thrombin Inhibitors
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationVitamin K Antagonist, Direct Thrombin Inhibitors, Novel Oral Anticoagulants (NOACs), Heparin
Key market players worldwideAspen Group Inc, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, Sanofi SA, Bayer AG, Boehringer Ingelheim, Daiichi Sankyo Co Ltd, Johnson & Johnson, Eisai Co Ltd


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.2% of the global anticoagulants market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia anticoagulants market is projected to lead the regional market in terms of revenue in 2033.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 191.0 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Anticoagulants Market Companies

Name Profile # Employees HQ Website
Eisai Co Ltd View profile 11076 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, Japan, 112-8088 http://www.eisai.co.jp
Daiichi Sankyo Co Ltd View profile 17435 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 https://www.daiichisankyo.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Aspen Group Inc View profile 1133 276 Fifth Avenue, Suite 505, New York, NY, United States, 10001 https://www.aspu.com
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

South Africa anticoagulants market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulants market will help companies and investors design strategic landscapes.


Novel oral anticoagulants (noacs) was the largest segment with a revenue share of 58.78% in 2025. Horizon Databook has segmented the South Africa anticoagulants market based on vitamin k antagonist, direct thrombin inhibitors, novel oral anticoagulants (noacs), heparin covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to South Africa anticoagulants market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Africa anticoagulants market databook

  • Our clientele includes a mix of anticoagulants market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa anticoagulants market , including forecasts for subscribers. This country databook contains high-level insights into South Africa anticoagulants market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Africa anticoagulants market size, by drug category, 2021-2033 (US$M)

South Africa Anticoagulants Market Outlook Share, 2025 & 2033 (US$M)

South Africa anticoagulants market size, by drug category, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online